These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30278937)

  • 1. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
    Yu PY; Beal EW; Hughes TM; Suarez-Kelly LP; Shelby RD; Ethun CG; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2018 Nov; 231():248-256. PubMed ID: 30278937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
    Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
    Singer S; Corson JM; Demetri GD; Healey EA; Marcus K; Eberlein TJ
    Ann Surg; 1995 Feb; 221(2):185-95. PubMed ID: 7857146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Le Pèchoux C; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Catton C; Casali PG; Wunder JS; Gronchi A
    Eur J Cancer; 2018 Dec; 105():19-27. PubMed ID: 30384013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
    Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
    Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
    Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
    Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
    Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
    Movva S; von Mehren M; Ross EA; Handorf E
    J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.
    Makris EA; Tran TB; Delitto DJ; Lee B; Ethun CG; Grignol V; Harrison Howard J; Bedi M; Clark Gamblin T; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; Poultsides G; Kirane A
    J Surg Oncol; 2024 Jun; 129(7):1354-1363. PubMed ID: 38562002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of margin width for extremity and trunk sarcoma.
    McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
    J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
    Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
    Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC.
    Acem I; van Houdt WJ; Grünhagen DJ; van der Graaf WTA; Rueten-Budde AJ; Gelderblom H; Verhoef C; ; van de Sande MAJ
    Eur J Cancer; 2022 Apr; 165():71-80. PubMed ID: 35219025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Radiation Therapy for Thoracic Soft Tissue Sarcomas: A Population-Based Analysis.
    Rehmani SS; Raad W; Weber J; Lazarev S; Ayub A; Al-Ayoubi AM; Bhora FY
    Ann Thorac Surg; 2020 Jan; 109(1):203-210. PubMed ID: 31520633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization pattern and survival outcomes of adjuvant therapies in high-grade nonretroperitoneal abdominal soft tissue sarcoma: A population-based study.
    Green WR; Chokshi R; Jabbour SK; DeLaney TF; Mahmoud O
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):101-113. PubMed ID: 28464497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
    Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
    J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for control of soft-tissue sarcomas resected with positive margins.
    Delaney TF; Kepka L; Goldberg SI; Hornicek FJ; Gebhardt MC; Yoon SS; Springfield DS; Raskin KA; Harmon DC; Kirsch DG; Mankin HJ; Rosenberg AE; Nielsen GP; Suit HD
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1460-9. PubMed ID: 17394945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI assessment of surrounding tissues in soft-tissue sarcoma during neoadjuvant chemotherapy can help predicting response and prognosis.
    Crombé A; Le Loarer F; Stoeckle E; Cousin S; Michot A; Italiano A; Buy X; Kind M
    Eur J Radiol; 2018 Dec; 109():178-187. PubMed ID: 30527301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The radiation dose-response of non-retroperitoneal soft tissue sarcoma with positive margins: An NCDB analysis.
    Wells S; Ager B; Hitchcock YJ; Poppe MM
    J Surg Oncol; 2019 Dec; 120(8):1476-1485. PubMed ID: 31710707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.